INSIGHTS ON CLINICAL TRIAL PARTNERING
-
![oncology-clinical-GettyImages-2228804507]( "The New Blueprint For Oncology Trials: Agility, Consistency, & Scale")
The New Blueprint For Oncology Trials: Agility, Consistency, & ScaleOncology trials are increasingly complex, exposing gaps in traditional operations; consistency, scalability, and agility help teams adapt faster and reduce inefficiencies.
-
![Group of doctors in meeting-GettyImages-2169868459]( "What Controlled Immune Challenges Reveal Before Patient Studies Begin")
What Controlled Immune Challenges Reveal Before Patient Studies BeginControlled immune challenges can reveal target engagement and pharmacology before efficacy is measurable, supporting earlier and more informed development decisions.
-
![Getty-668224090-Field Service Recruitment]( "On-Demand Service Models Improve Clinical Trials")
On-Demand Service Models Improve Clinical TrialsAs consumers increasingly expect convenience and immediacy, the on-demand model continues to reshape how services are delivered across nearly every sector.
-
![RTSM Software Isn’t One-Size-Fits-All Especially For Biotechs]( "RTSM Software Isn't One-Size-Fits-All, Especially For Small Biotechs")
RTSM Software Isn't One-Size-Fits-All, Especially For Small BiotechsSmaller biotech companies often have very different clinical trial needs than large pharmaceutical organizations, and that includes RTSM.
-
Routes To Sponsor Of Choice: Shared Pipelines, Streamlined Payments10/30/2024
Paying clinical trial sites consistently on time provides stability and maintains positive relationships. Learn why being a sponsor of choice can mean the adoption of a singular clinical trial payments solution.
-
Key Strategies For Clinical Development In Rare Cancers2/11/2025
Successful execution of rare cancer clinical trials requires strategic patient recruitment, innovative trial design, and specialized expertise from Oncology CROs.
-
Faster Starts, Stronger Finish: Operational Excellence In NSCLC5/22/2026
In NSCLC trials, data‑driven site selection, streamlined protocols, efficient screening strategies, and proactive engagement can accelerate enrollment and improve trial efficiency across regions.
-
Evidence Of An Industry's Readiness To Collaborate11/13/2024
The effort to build a single home for sites to access their trial systems has demonstrated that the industry is ready to forego competitive discourse to deliver benefits to sites and patients.
-
Beyond A Single Disease: Traversing Complexity In Breast Cancer Clinical Development9/8/2026
Biomarkers, new therapies, and tough enrollment hurdles are reshaping breast cancer trials. Get the insights to plan smarter.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
![Finance GettyImages-1330234595]( "Greenphire Clinical Finance: Budgeting & Benchmarking")
Streamline trial budgets and payments with real-time fair market data, speeding startups and ensuring timely, transparent site funding worldwide.
-
![GettyImages-1083316464_eye]( "Your Top Partner For Ophthalmic Drug Development")
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
-
![GettyImages-1326241306-research-computer-brain-scan]( "Rave Imaging: Elevate Your Imaging Strategy")
With this single, purpose-built platform, uncover how sponsors can deliver greater quality, oversight, and efficiency throughout the entire imaging lifecycle.
-
![GettyImages-1226390663-CRA- Clinical Research Associate]( "Starting A New Study? This One's For You")
Choosing the right vendor at trial launch impacts costs, timelines, data integrity, and patient experience — yet vendor selection in clinical research remains fundamentally broken today.
-
![GettyImages-2152658176 oncology, doctor, patient]( "Oncology CRO Helping To Bring Cancer Therapies To Patients")
Niche CRO with a difference
Worldwide Clinical Trials Oncology is a niche oncology CRO devoting time, energy, and capital to supporting biotechs in bringing next-generation therapies to patients in need. Oncology clinical research is complex, demanding, and continually evolving. Bringing effective therapies to proof-of-concept and then to market as fast as possible is our passion because every second counts for patients with cancer and their families.
